China Money Network
Login
Join

Riverhead Capital Co-Leads $186M Series B Round In Chinese Lepu Biotech

  • August 6, 2020 — 13:11 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese innovative biotech firm Lepu Biotech completed a nearly RMB1.291 billion(US$186 million) series B round of financing co-led by Riverhead Capital, Sunshine Insurance Group and... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: